First-line immune-checkpoint inhibitor plus chemotherapy versus chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysis

INTRODUCTION: Platin-based chemotherapy (CT) has long been the first-line standard-of-care for patients with extensive-stage small-cell lung cancer (ES–SCLC). Adding immune-checkpoint inhibitor(s) to CT (ICI+CT) in this setting is an option of interest, although its benefit is apparently modest. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Landre, Thierry, Chouahnia, Kader, Des Guetz, Gaëtan, Duchemann, Boris, Assié, Jean-Baptiste, Chouaïd, Christos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731693/
https://www.ncbi.nlm.nih.gov/pubmed/33343721
http://dx.doi.org/10.1177/1758835920977137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731693/
https://www.ncbi.nlm.nih.gov/pubmed/33343721
http://dx.doi.org/10.1177/1758835920977137

Ejemplares similares